ASX Share rice
Wed 12 Aug 2020 - 10:58:am (Sydney)

GSS Share Price

GENETIC SIGNATURES LIMITEDGSSPharmaceuticals, Biotechnology & Life Sciences

GSS Company Information

Name:

Genetic Signatures Limited

Sector:

Healthcare

Industry:

Medical Laboratories & Research

GIC Industry:

Life Sciences Tools & Services

GIC Sub Industry:

Life Sciences Tools & Services

Address:

7 Eliza Street Sydney NSW Australia 2042

Phone:

61 2 9870 7580

MD, CEO & Exec. Director:

Dr. John R. Melki

CFO & Company Sec.:

Mr. Peter Manley

Exec. Director of US Operations & Exec. Director:

Mr. Michael Anton Aicher M.B.A., BSc, MBA

Founder & Chairman Emeritus:

Mr. Christopher M. Abbott

Chief Scientific Officer:

Dr. Douglas S. Millar BSc, Ph.D.

Company Overview:

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in North America and Australia. The company designs and manufactures a suite of real-time polymerase chain reaction based products for detection of infectious diseases under EasyScreen brand name. It also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, the company offers MethylEasy for DNA bisulphite modification of histones for screening of cancer and embryonic development, as well as use in stem cell technologies. Genetic Signatures Limited was founded in 2001 and is headquartered in Sydney, Australia.

GSS Share Price Information

Shares Issued:

142.32M

Market Capitalisation:

$327.35M

Revenue (TTM):

$7.27M

Revenue Per Share (TTM):

$0.07

Earnings per Share:

$-0.034

Profit Margin:

-0.5622

Operating Margin (TTM):

$-0.57

Return On Assets (TTM):

$-0.09

Return On Equity (TTM):

$-0.15

Quarterly Revenue Growth (YOY):

0.072

Gross Profit(TTM):

$4.16M

Diluted Earnings Per Share (TTM):

$-0.038

GSS CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$-610,687

Change To Liabilities:

$277.37K

Total Cashflow From Investing Activities:

$-610,687

Net Income:

$-3,491,994

Total Cash From Operating Activities:

$-2,268,979

Depreciation:

$470.75K

Change To Inventory:

$-172,613

Change To Account Receivables:

$-100,460

Sale Purchase Of Stock:

$-5,652

Capital Expenditures:

$610.69K

GSS Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-3,491,994

Net Income:

$-3,491,994

Gross Profit:

$3.18M

Operating Income:

$-5,757,794

Other Operating Expenses:

$1.30M

Interest Expense:

$519

Total Revenue:

$4.87M

Total Operating Expenses:

$8.94M

Cost Of Revenue:

$1.69M

GSS Balance Sheet

Balance Sheet Date:

2019-06-30

Total Liabilities:

$1.56M

Total Stockholder Equity:

$10.57M

Other Current Liabilities:

$486.04K

Total Assets:

$12.13M

Common Stock:

$47.03M

Other Current Assets:

$2.15M

Retained Earnings:

$-37,827,766

Other Liabilities:

$19.26K

Cash:

$6.31M

Total Current Liabilities:

$1.54M

Property - Plant & Equipment:

$1.46M

Net Tangible Assets:

$10.57M

Total Current Assets:

$10.67M

Net Receivables:

$716.62K

Short-Term Investments:

$1.46M

Inventory:

$1.35M

Accounts Payable:

$565.24K

Non Currrent Assets (Other):

$1.46M

Short-Term Investments:

$1.46

Non Current Liabilities Total:

$19.26K

GSS Share Price History

GSS News

31 Jul, 2020
Genetic Signatures Limited (ASX:GSS) shareholders will have a reason to smile today, with the covering analyst making...
08 May, 2020
Celebrations may be in order for Genetic Signatures Limited (ASX:GSS) shareholders, with the covering analyst...
20 Apr, 2020
For many, the main point of investing in the stock market is to achieve spectacular returns. While not every stock...
21 Feb, 2020
John Melki has been the CEO of Genetic Signatures Limited (ASX:GSS) since 2011. First, this article will compare CEO...
23 Dec, 2019
Genetic Signatures Limited's (ASX:GSS): Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in...
23 Oct, 2019
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But in contrast you can...
23 Sep, 2019
Just because a business does not make any money, does not mean that the stock will go down. For example, although...